The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis
Haberal, M.; Sert, S.; Gülay, H.; Arslan, G.; Bilgin, N.
Transplantation Proceedings 22(4): 1761-1763
1990
ISSN/ISBN: 0041-1345 PMID: 2117801 Document Number: 366583
Document emailed within 1 workday
Related Documents
Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U. 1988: OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a Transplantation Proceedings 20(5 Suppl 6: 90-95
Palmer, J.; Slook, P. 1992: Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients Anna Journal 19(4): 375-377
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Vialtel, P.; Chenaise, F.; Dechelette, E.; Bayle, F.; Cordonnier, D.; Seigneurin, J.M. 1978: Massive plasmapheresis in the treatment of acute graft rejection resistant to usual treatment La Nouvelle Presse Medicale 7(30): 2663
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Rifle, G.; Chalopin, J.M.; Turc, J.M.; Guigner, F.; Vialtel, P.; Dechelette, E.; Chenais, F.; Cordonnier, D. 1979: Plasmapheresis in the treatment of renal allograft rejections Transplantation Proceedings 11(1): 20-26
Stuart, F.P.; Fitch, F.W.; Rowley, D.A. 1970: Specific suppression of renal allograft rejection by treatment with antigen and antibody Transplantation Proceedings 2(4): 483-488
Nickel, P.; Lacha, J.; Ode-Hakim, S.; Sawitzki, B.; Babel, N.; Frei, U.; Volk, H.D.; Reinke, P. 2001: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft Transplantation 72(6): 1158-1160
Paul, L.C.; Chea, R.; Davidoff, A.; Benediktsson, H. 1994: Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat Transplantation Proceedings 26(5): 2567-2568
d'Apice, A.J.; Thurlow, P.J.; Ihle, B.U.; Lovering, E.K.; McKenzie, I.F. 1987: Treatment of acute renal allograft rejection with a monoclonal antibody to a T cell antigen (HuLy-m2) Australian and New Zealand Journal of Medicine 17(2): 210-215
Kountz, S.L.; Rao, T.K.; Butt, K.H. 1975: The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection Transplantation Proceedings 7(1): 73-77
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Winde, G.; Dietl, K.H.; Raidt, H.; Buchholz, B.; Lison, A.E.; Bünte, H. 1988: Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation Transplantation Proceedings 20(5 Suppl 6: 87-89
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Woodle, E.S.; Xu, D.; Zivin, R.A.; Auger, J.; Charette, J.; O'Laughlin, R.; Peace, D.; Jollife, L.K.; Haverty, T.; Bluestone, J.A.; Thistlethwaite, J.R. 1999: Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection Transplantation 68(5): 608-616
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Kondo, Y.; Okamura, T. 1974: Pathology of renal allograft rejection Rinsho Byori. Japanese Journal of Clinical Pathology 22(6): 416-420
Jirka, J.; Rosmann, P.; Málek, P.; Reneltová, I.; Matousovic, K.; Kocandrle, V. 1978: Rejection of human renal allograft Czechoslovak Medicine 1(2): 69-74
Bolton, E.M.; Armstrong, H.E.; Briggs, J.D.; Bradley, J.A. 1987: Cellular requirements for first-set renal allograft rejection Transplantation Proceedings 19(1 Part 1): 321-323